Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Wafety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2009
At a glance
- Drugs SYI 2074 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 14 Oct 2009 New trial record.